It's Time For-Jdrf-Tucson-Curing Type 1 Diabetes
JDRF works towards a day when there is no more type 1 diabetes. Type 1 diabetes is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. In type 1 diabetes, the body does not produce insulin. Diabetes – is a problem with your body that causes blood glucose (sugar) levels to rise higher than normal. This is also called hyperglycemia. When you eat your body breaks food down into glucose and sends it into the blood. Insulin then helps move the glucose from the blood into your cells. When glucose enters your cells, it is either used as fuel for energy right away or stored for later use. In a person with diabetes, there is a problem with insulin. But, not everyone with diabetes has the same problem. There are different types of diabetes – type 1, type 2, and a condition called gestational diabetes, which happens during pregnancy. If you have diabetes, your body either doesn’t make enough insulin, it can’t use the insulin it does make very well, or both. Tucson is the “arts mecca” of the American Southwest, offering a wealth of cultural activities: theater, opera, ballet, and symphony, as well as galleries and museums. The Tucson Arts District Partnership lies in the heart of downtown Tucson and includes the Tucson Music Hall, the Tucson Community Center, and the Temple of Music and Art. Tucson’s Arizona Theatre Company, the leading professional theater company in the state, has received national recognition, including grants and citations from the Ford Foundation, the National Endowment of the Arts, and the White House Committee on the Arts. Its productions range from the classics to recent Broadway hits during a September-to-April season at the Temple of Music and Art. Off-Broadway shows and musicals are the forte of the Invisible Theatre, while a.k.a. Theatre presents experimental and modern works. Since its founding more than 40 years ago by parents of children affected by type 1 diabetes, the Juvenile Diabetes Research Foundation (JDRF) has been committed to finding a cure for all those individuals living with the disease. Today, JDRF acknowledges that this commitment will not likely be fulfilled in the near term. Although our ultimate goal—curing type 1 diabetes—remains unchanged, we are equally committed to better treating and preventing the disease. These goals aim to ensure that both children and adults living with type 1 diabetes remain healthy so that they can fully benefit from a cure when it becomes available. JDRF focuses on supporting the development and delivery of new therapies and devices that will ease the daily burden and challenges of managing type 1 diabetes and on the prevention of diabetes complications. Additionally, to protect future generations from developing type 1 diabetes, JDRF is supporting approaches to prevent the disease. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services All Video Credits are listed here http://broadcaster.beazil.net/public/credits/youtube/videos/42056 JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
The main points are –
Blood Sugar,borderline diabetes,T1D patterns,DPP,Blood Glucose,Accredited Charity,Team Research,ketone,impaired glucose tolerance,make a tax-deductive donation,Cure,Top Research Highlights,diabetes related complications,save a life,The Promise Campaign,injectable long-acting insulin,thiazolidinedione,fasting lipid profile,T1D Triggers,Ketoacidosis,worldwide effort,NPH Humulin N,Humulin R,donate to help,Aldesleukin,JDRF lobbies,hyperglycemic crisis,Affects of Diabetes,insulin therapy,NIDDM,glycemic control,children diabetes,IDDP program,low-density lipoprotein cholesterol,uncontrolled hyperglycemia,low blood glucose,insulin dependent diabetes,Managing a hypo,unit of insulin,DILfrequency study,T1D community,Carol.